Yoleimys Lizeth Fuentes Araujo

Yoleimys Lizeth Fuentes Araujo

Auto-generated profile, based on publicly available information

Yoleimys Lizeth Fuentes Araujo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
AHAndres Felipe Herrera Homez
Andres Felipe Herrera Homez
HMHillary Yahiry Mejía Montiel
Hillary Yahiry Mejía Montiel
MGMaría Camila Fontecha Garzón
María Camila Fontecha Garzón
YAYoleimys Lizeth Fuentes Araujo
Yoleimys Lizeth Fuentes Araujo
MTMaría Fernanda Banderas Torres
María Fernanda Banderas Torres
CHClaudia Zamaly Ferreira Hernández
Claudia Zamaly Ferreira Hernández
Cutaneous immunity operates through a complex integration of structural, microbial, cellular, and neuroimmune mechanisms that collectively determine the skin’s ability to maintain homeostasis and respond to injury or inflammation. This review synthesizes contemporary evidence on epidermal barrier dysfunction, microbiome dysbiosis, antigen-presenting cell networks, tissue-resident memory T cells, and neuroimmune signaling to construct a comprehensive model explaining the pathophysiology of major inflammatory dermatoses, including atopic dermatitis, psoriasis, and allergic contact dermatitis. Key findings highlight barrier impairment as an initiating factor in immune activation, microbial imbalance—particularly Staphylococcus aureus overgrowth—as a powerful amplifier of inflammatory responses, and specialized immune circuits as central drivers of chronicity. Neuroimmune interactions, although less frequently explored, emerge as critical contributors to persistent pruritus and symptom exacerbation. The integration of these mechanisms provides a unified framework that enhances understanding of disease heterogeneity and supports the development of targeted, context-specific approaches relevant to diverse populations such as those in Mexico, Colombia, and Ecuador. This multidimensional perspective reaffirms the skin as a fully active immune organ and underscores the value of coordinated strategies that address structural integrity, microbial ecology, immune regulation, and neural pathways.

8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
ARArizbeth Miroslava Pinales Ramírez
Arizbeth Miroslava Pinales Ramírez
PJPamela Elizabeth Peñaloza Jiménez
Pamela Elizabeth Peñaloza Jiménez
KCKarla Stefanny Naranjo Calvachi
Karla Stefanny Naranjo Calvachi
JLJesús Ricardo Jiménez López
Jesús Ricardo Jiménez López
JHJohn Anthony García Hernández
John Anthony García Hernández
EREloisa Vanessa Suárez Ruiz
Eloisa Vanessa Suárez Ruiz
Regenerative medicine has rapidly evolved into a central pillar of aesthetic and reconstructive surgery, integrating cellular therapies, autologous biologics, biomaterials and advanced biofabrication platforms. This review synthesizes evidence from twenty peer-reviewed studies to examine how these modalities contribute to tissue restoration, improve structural and functional outcomes and reshape surgical practice. Cell-based approaches—particularly mesenchymal and adipose-derived stem cells—emerged as the most frequently investigated strategies, reflecting their capacity to modulate inflammation, enhance angiogenesis and promote extracellular matrix remodeling. Autologous biologics such as platelet-rich plasma and regenerative fat grafting also demonstrated widespread application due to their accessibility and compatibility with established clinical workflows. Concurrently, biomaterial-based techniques and 3D bioprinting technologies are expanding reconstructive possibilities, enabling more personalized and anatomically precise interventions. Across indications ranging from facial rejuvenation and breast reconstruction to cartilage engineering and wound repair, regenerative modalities consistently demonstrated potential to improve tissue quality and aesthetic outcomes. Although heterogeneity in protocols and limited long-term data remain challenges, the convergence of biological science, materials engineering and surgical innovation positions regenerative medicine as a transformative paradigm for future clinical practice.

10 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
JAJosé Enrique González Araujo
José Enrique González Araujo
YAYoleimys Lizeth Fuentes Araujo
Yoleimys Lizeth Fuentes Araujo
SGSebastián Felipe Peralta González
Sebastián Felipe Peralta González
JQJosé Uriel Cornejo Quezada
José Uriel Cornejo Quezada
CCCristian Alonso Duarte Carreño
Cristian Alonso Duarte Carreño
GZGiancarlo Ottelo Amory Zambrano
Giancarlo Ottelo Amory Zambrano
Multimorbidity has become a defining challenge for internal medicine, characterized by the coexistence of multiple chronic diseases and shaped by functional decline, treatment burden, and socioeconomic vulnerability. This review synthesizes contemporary evidence on the epidemiology, clinical consequences, and health-system implications of multimorbidity, with a particular focus on Mexico, Colombia, and Ecuador. Findings demonstrate steep age-related increases in prevalence, strong associations with mortality, hospitalization, disability, and elevated costs, and significant variability driven by methodological differences and inequities in access to care. Functional impairment consistently emerges as a central predictor of adverse outcomes, underscoring the need for geriatric-informed, person-centered approaches. Despite extensive observational research, interventional and policy-oriented studies remain limited, especially in middle-income settings. The review highlights the urgent need for integrated care models, improved coordination between internal medicine and primary care, and equity-oriented policies capable of responding to the complex trajectories of multimorbidity. By integrating theoretical, epidemiological, and health-system perspectives, this study provides a foundation for advancing research, guiding clinical decision-making, and informing system reforms in Latin American internal medicine.